MGH study shows B cell therapy may ease ARDS by reducing lung damage, improving oxygenation, and restoring immune balance in preclinical models.

BOSTON – Beth Israel Deaconess Medical Center (BIDMC) has been named by U.S. News & World Report a 2025-2026 Best Hospital. BIDMC was ranked among the top 50 hospitals nationwide in nine adult ...

BIDMC’s clinical collaboration with Dana-Farber, with the creation of a new cancer hospital, is moving forward after the completion of the regulatory process.

BIDMC and Dana-Farber Cancer Institute's construction of the region’s only freestanding inpatient cancer hospital has been approved by the city of Boston.

BIDMC earned an ‘A’ from The Leapfrog Group for spring 2025, recognizing its strong commitment to patient safety and high-quality care.

Dr. Blair J. Wylie joins Beth Israel Deaconess Medical Center as Chair of Obstetrics and Gynecology, leading clinical services, research, and educational initiatives.

A new multi-site study by BIDMC, MGH, BWH, and CDC aims to enhance pandemic preparedness and understand respiratory virus transmission through the CHARM Network.

In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults ...

BIDMC is one of the award recipients for the ARPA-H Sprint for Women’s Health, and will use it to assess brain disorders in women. Learn about the project.

Beth Israel Lahey Health, Inc. (the “Applicant”), with a principal place of business at 20 University Road, Suite 700, Cambridge, Massachusetts, intends to file a Notice of Determination of Need (“DoN ...

BIDMC researchers used state-level data to evaluate the link between restricted abortion access and and entries into the foster care system. Read more.